RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lee Dupuis, RPh, PhD
The Hospital for Sick Children
Principal Investigator - Muhammad Ali, MD
The Hospital for Sick Children
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Manitoba
Winnipeg, Manitoba, Canada
Recruiting - Hospital for Sick Children
Toronto, Ontario, Canada
Recruiting - Centre Hospitalier Universitaire Sainte-Justine,
Montreal, Quebec, Canada
Terminated
- All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, India
Recruiting
- University of California
San Francisco, California, United States
Recruiting - the Children'S Mercy Hospital
Kansas City, Missouri, United States
Recruiting - Columbia University/morgan Stanley Children'S Hospital
New York, New York, United States
Withdrawn - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting - Nationwide Children'S Hospital
Columbus, Ohio, United States
Recruiting - Medical University of South Carolina
Charleston, South Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Aug 2017
- Primary completion
- 31 Mar 2026
- Completion
- 30 Apr 2026
- Last update posted
- 8 Oct 2025
- Registered enrollment
- 200
- Registry id
- NCT03118986
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.